The contrarian in me says that when everybody’s bullish about everything, it’s time to get a little cautious,’ says John ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $32.00. The ...

Pfizer's PFE short percent of float has risen 20.9% since its last report. The company recently reported that it has 91.78 million shares sold short, which is 1.62% of all regular ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

Shares of Pfizer Inc. PFE rallied 1.09% to $26.91 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.53% to 6,071.17 and ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...

Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences (GILD – Research Report) yesterday and set a price target of ...

Shares in Amazon ( AMZN) are up nearly 46% over the past year, with the stock hitting a record high closing price of $238.15 ...

India is a marketplace booming with smartphones duking it out on various price points. From the killer-budget phones to the ultra-flagships, there is a phone for everyone. Of course, the market ...

The stock market bounced around in the final half-hour of trading as markets reacted to comments from President Donald Trump ...

Bristol-Myers Squibb gets rated a hold, as I see future value in its clinical portfolio and pipeline, particularly ...